Amendment: SEC Form SCHEDULE 13D/A filed by Exicure Inc.
$XCUR
Biotechnology: Pharmaceutical Preparations
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)
|
EXICURE, INC. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
30205M309 (CUSIP Number) |
Dario Lee 1500 W Georgia st, Suite 1323 Vancouver, A1, V7Y1C6 2368386944 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
01/16/2026 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 30205M309 |
| 1 |
Name of reporting person
Exicure HiTron Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
KOREA, REPUBLIC OF
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,857,314.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
29.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock | |
| (b) | Name of Issuer:
EXICURE, INC. | |
| (c) | Address of Issuer's Principal Executive Offices:
2430 N. HALSTED ST., CHICAGO,
ILLINOIS
, 60614. | |
Item 1 Comment:
This Amendment No. 4 (this Amendment) to the statement on Schedule 13D with respect to the beneficial ownership of shares of common stock, par value $0.0001 per share (the Shares), of Exicure, Inc., a Delaware corporation (the Issuer), filed by Exicure HiTron Inc., a South Korean corporation (the Reporting Person), amends and supplements the statement on Schedule 13D originally filed on November 29, 2024, as amended by Amendment No. 1 filed on November 19, 2024, Amendment No. 2 filed on September 9, 2025, and Amendment No. 3 filed on January 9, 2026 (collectively, the Original Statement), as set forth below.
All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Statement. Except as specifically amended by this Amendment, the Original Statement remains unchanged
| ||
| Item 3. | Source and Amount of Funds or Other Consideration | |
Item 3 of the Original Statement is hereby amended and supplemented as follows:
On January 16, 2026, the Reporting Person completed the Share Transfer (as defined in Item 4 of this Amendment), pursuant to which the Reporting Person transferred an aggregate of 734,747Shares at a purchase price of $4.50 per Share, or $3,306,361.5 in the aggregate
| ||
| Item 4. | Purpose of Transaction | |
Item 4 of the Original Statement is hereby amended and supplemented as follows:
The Reporting Person entered into share transfer agreements dated December 30, 2025 (the Share Transfer Agreements) and agreed to transfer (the Share Transfer) an aggregate of 734,747 Shares at a price of $4.50 per Share for aggregate proceeds of $3,306,361.5, as follows:
Name of Transferee Number of Shares Proceeds
Daolam Co,. Ltd 246,913 $1,111,108.5
Lee So Jung 243,918 $1,097,631
Kim Jun Sue 243,916 $1,097,622
| ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | Item 5(a) of the Original Statement is hereby amended and restated as follows:
The percentage of beneficial ownership reported in this Item 5, and on the Reporting Persons cover page to this Amendment, is based on a total of 6,373,869 shares of common stock, which represents the number of shares of common stock reported as outstanding on November 3, 2025, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. All share numbers reported herein, and on the Reporting Persons cover page to this Amendment, are as of January 16, 2026, and give effect to the share transfers described herein. The cover page to this Amendment is incorporated by reference in its entirety into this Item 5. As of January 16, 2026. The Reporting Person is the beneficial owner of 1,857,314 shares of Common Stock, representing approximately 29.2% of the outstanding shares of Common Stock.
| |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
Item 6 of the Original Statement is hereby supplemented as follows:
The Reporting Person entered into share transfer agreements and agreed to transfer an aggregate of 734,747 Shares at a price of $4.50 per Share for aggregate proceeds of $3,306,361.5, as follows:
Name of Transferee Number of Shares Proceeds
Daolam Co,. Ltd 246,913 $1,111,108.5
Lee So Jung 243,918 $1,097,631
Kim Jun Sue 243,916 $1,097,622
| ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|